| 219.34 Delayed Data As of Aug 16 |  +4.13 / +1.92%Today’s Change | 136.44 Today|||52-Week Range 220.48 | +43.20% Year-to-Date |
| HMS Holdings (HMSY) Soars to 52-Week High, Time to Cash Out? Aug 14 / Zacks.com - Paid Partner Content | Here is Why Growth Investors Should Buy Edwards Lifesciences (EW) Now Aug 13 / Zacks.com - Paid Partner Content |
| Previous close | 215.21 |
| Today’s open | 218.00 |
| Day’s range | 217.01 - 220.48 |
| Volume | 1,082,765 |
| Average volume (3 months) | 1,273,260 |
| Market cap | $45.2B |
| Earnings growth (last year) | +24.55% |
| Earnings growth (this year) | +13.61% |
| Earnings growth (next 5 years) | +11.67% |
| Revenue growth (last year) | +8.37% |
| P/E ratio | 64.1 |
| Price/Sales | 8.79 |
| Price/Book | 14.39 |
| Today’s change | Today’s % change | |
|---|---|---|
| ISRGIntuitive Surgical | -4.42 | -0.88% |
| SNNSmith & Nephew PLC | +0.64 | +1.40% |
| STESteris plc | +0.77 | +0.51% |
| SYKStryker Corp | +1.70 | +0.79% |
| Next reporting date | October 24, 2019 |
| EPS forecast (this quarter) | $1.22 |
| Annual revenue (last year) | $3.7B |
| Annual profit (last year) | $722.2M |
| Net profit margin | 19.40% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Michael A. Mussallem |
Chief Financial Officer & Vice President Scott B. Ullem |
Corporate headquarters Irvine, California |
